Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Medical Properties Trust's CEO Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript)

Stock quotes in this article: MPW 

Medical Properties Trust, Inc. (MPW)

Bank of America Merrill Lynch 2012 Health Care Conference Call

May 16, 2012 4:40 pm ET

Executives

Edward K. Aldag Jr. – Chairman, President and Chief Executive Officer

R. Steven Hamner – Executive Vice President and Chief Financial Officer

Analysts

Armando Lopez – Bank of America/Merrill Lynch

Presentation

Armando Lopez – Bank of America/Merrill Lynch

I am Armando Lopez; I am with Bank of America Merrill Lynch. And it’s my pleasure today to introduce Medical Properties Trust. Today, for Medical Properties Trust we have Chairman, President and Chief Executive Officer, Mr. Ed Aldag. With him today, we also have the companies Chief Financial Officer, Steve Hamner, and the Finance Director and Head of Investor Relations, Charles Lambert.

Before I turn the floor over to Ed, I would like to provide a brief background Ed has served as Chairman and President and Chief Executive Officer of Medical Properties Trust since it was founded in August of 2003, prior to that he spent 15 years at Guilford Capital Corporation and Guilford Medical Properties. Mr. Aldag, was the President and a member of the Board of Directors of Guilford Capital from 1990 to 2001, serving as Executive Vice President, Chief Operating Officer and a member of the Board of Directors. He also served as President and a member of the Board of Directors of Guilford Medical Properties from its inception until selling his interest in the company in 2001. He received a Bachelors Degree in Commerce and Business from the University of Alabama and it’s my pleasure to welcome Mr. Ed Aldag. Ed?

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs